리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 08월
페이지 정보:영문 377 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 저침습 척추 기기 시장은 2030년까지 14억 달러에 이를 전망
2024년에 10억 달러로 추정되는 저침습 척추 기기 세계 시장은 2024-2030년간 CAGR 5.0%로 성장하여 2030년에는 14억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 내시경 기기는 CAGR 6.3%를 나타내고, 분석 기간 종료시에는 5억 8,200만 달러에 이를 것으로 예측됩니다. 투시 기기 부문의 성장률은 분석 기간에 CAGR 3.4%로 추정됩니다.
미국 시장은 추정 2억 7,860만 달러, 중국은 CAGR 8.2%로 성장 예측
미국의 저침습 척추 기기 시장은 2024년에 2억 7,860만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 8.2%로 2030년까지 2억 7,620만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 2.3%와 5.1%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.3%를 나타낼 전망입니다.
세계의 저침습 척추 기기 시장 - 주요 동향과 촉진요인 정리
저침습 척추 기기는 척추 수술과 환자 회복에 어떤 혁명을 일으키고 있는가?
저침습 척추 기기는 조직 외상을 줄이고 회복 시간을 단축하며 전반적인 수술 결과를 개선하는 솔루션을 제공함으로써 척추 수술 분야를 획기적으로 재구성하고 있습니다. 기존의 관혈적 척추 수술은 근육과 조직을 광범위하게 파괴하기 때문에 큰 절개, 장기 입원, 장기 재활이 필요한 경우가 많습니다. 반면, 최소침습적 시술은 특수한 장치와 기구를 사용하여 투시나 수술 중 내비게이션 시스템 등의 실시간 영상으로 유도하면서 작은 절개창을 통해 척추에 접근하는 방식입니다. 이러한 시술은 출혈이 적고, 수술 후 통증이 적으며, 환자의 이동이 빨라집니다. 튜브 리트랙터, 내시경 도구, 경피적 페디클 스크류 등의 장비를 통해 외과의사는 추간판탈출증, 척추관 협착증, 퇴행성 추간판증 등의 척추 질환을 주변 구조를 보존하면서 높은 정확도로 치료할 수 있습니다. 영상 진단과 기구의 혁신으로 척추 고정술, 변형 교정술 등 보다 복잡한 수술도 최소 침습적 접근으로 할 수 있게 되었습니다. 이 전환은 환자의 회복에 도움이 될 뿐만 아니라 수술실의 효율성을 개선하고 감염 및 인접 부문 퇴행과 같은 합병증의 위험을 낮춥니다. 외과의사들은 임상 결과와 더 빠르고 덜 침습적인 시술에 대한 환자들의 요구가 증가함에 따라 더 광범위한 척추 질환을 치료하기 위해 이러한 장비를 점점 더 많이 채택하고 있습니다. 그 결과, 저침습 척추 기기는 수술 치료의 새로운 기준을 세우고 병원이 비용을 절감하면서 우수한 환자 결과를 달성할 수 있도록 돕고 있습니다.
고령화 사회와 활동적인 라이프 스타일 속에서 저침습 척추 기기에 대한 수요가 급증하는 이유는 무엇인가?
저침습 척추 기기에 대한 수요는 전 세계적으로 급증하고 있으며, 그 주요 원동력은 인구 동향과 환자들의 기대치 변화입니다. 시장 성장의 가장 큰 요인 중 하나는 고령화 사회의 척추 질환 유병률 증가입니다. 전 세계적으로 평균 수명이 늘어나면서 척추관협착증, 척추전방전위증, 골다공증성 골절 등 노화 관련 질환의 발생률도 증가하고 있습니다. 저침습 수술은 수술에 따른 생리적 부담을 줄이고 노인에게 흔한 합병증 위험을 낮추기 때문에 고령 환자에게 특히 적합합니다. 또한, 오늘날의 노인들은 이전 세대보다 더 활동적이며, 기존의 개복 수술에 따른 장기간의 회복 기간을 견디지 않으려는 경우가 많습니다. 기타에도 스포츠 부상이나 업무 관련 척추 외상을 입은 젊은 환자들도 다운타임을 최소화하고 일상 활동으로 빠르게 복귀할 수 있는 솔루션을 원하고 있습니다. 이처럼 다양한 연령층의 니즈가 수렴되면서 첨단 저침습 장비의 도입이 활발하게 이루어지고 있습니다. 또한, 신흥국의 의료 인프라와 보험 적용 범위가 개선됨에 따라 더 많은 환자들이 이러한 치료법을 더 쉽게 이용할 수 있게 되었습니다. 인구 통계학적 변화, 인식의 변화, 수술의 가용성 확대와 함께 최소침습 척추 장치 시장은 현대 정형외과 및 신경학 치료의 최전선에 서게 되었습니다.
기술의 발전은 어떻게 저침습 척추 기기의 능력을 확장하고 있는가?
기술의 발전은 저침습적 척추 기기의 능력을 확장하여 그 어느 때보다 정밀하고 다재다능한 환자 맞춤형 치료를 가능하게 하고 있습니다. 로봇 보조 수술, 내비게이션 시스템, 실시간 영상 처리의 혁신은 외과 의사가 복잡한 수술을 보다 정확하고 건강한 조직에 대한 손상을 최소화하면서 수행할 수 있도록 돕고 있습니다. 로봇 플랫폼은 기기 설치 시 제어와 일관성을 강화하고, 수술 결과를 향상시키고, 편차를 줄여 수술 결과를 향상시킵니다. 3D 이미지와 증강현실(AR) 오버레이를 사용하는 수술 중 내비게이션 시스템은 상세한 해부학적 시각화를 가능하게 하여 외과 의사가 임플란트 위치를 최적화하고 중요한 구조물을 피할 수 있도록 돕습니다. 동시에 척추 임플란트 디자인도 크게 발전하고 있으며, 티타늄 합금, 폴리에테르에테르케톤(PEEK) 등의 신소재는 생체 적합성, 강도, 방사선 투과성이 향상되고 있습니다. 확장 가능한 몸통 간 케이지와 모듈식 고정 시스템은 환자 개개인의 고유한 요구에 맞는 맞춤형 척추 정렬과 하중 분담을 용이하게 해줍니다. 또한, 기구의 소형화와 인체공학적 개선으로 수술 중 절개창의 축소와 기구의 신속한 교체가 가능해졌습니다. 현재 일부 장비는 생물학적 제제 전달 시스템을 내장하고 있으며, 골이식재를 동시에 배치하여 유합률을 향상시킬 수 있습니다. 데이터 분석과 AI를 수술 계획에 통합하여 수술 도구의 선택과 사용을 더욱 개인화하여 다양한 환자 프로파일에 가장 적합한 결과를 제공합니다. 이러한 기술이 더욱 정교해지고 널리 채택됨에 따라 척추 수술의 표준 치료를 재정의하고 최소 침습적 접근법으로 달성할 수 있는 한계를 넓혀가고 있습니다.
전 세계 저침습 척추 기기 시장의 주요 성장 동력은 무엇인가?
저침습 척추 기기 시장의 성장은 전 세계적으로 척추 치료를 재편하고 있는 임상적, 기술적, 인구통계학적, 경제적 요인의 조합에 의해 주도되고 있습니다. 가장 큰 원동력 중 하나는 수술 후 통증 감소, 입원 기간 단축, 빠른 회복, 합병증 발생률 감소 등 저침습 수술의 임상적 이점이 입증되었습니다는 점입니다. 이러한 치료 효과는 환자 만족도를 높이고 전체 치료 비용을 절감할 수 있기 때문에 의료 제공업체와 지불자 모두에게 매력적인 접근 방식입니다. 환자들 사이에서도 이러한 장점에 대한 인식이 높아지면서, 특히 수술 옵션에 대한 정보가 온라인과 의료 네트워크를 통해 더 광범위하게 제공됨에 따라 점점 더 많은 환자들이 최소침습적 솔루션을 찾고 있습니다. 의료 제공업체 입장에서 병원과 수술센터는 수요를 충족하고 처리 능력을 높이고 성장하는 척추 외래 수술 분야에서 경쟁력을 유지하기 위해 이러한 수술을 우선순위에 두고 있습니다. 기술의 발전으로 저침습적인 방법으로 보다 광범위한 척추 질환을 치료할 수 있게 됨에 따라 대응 가능한 시장이 확대되어 보다 폭넓은 도입이 촉진되고 있습니다. 또한, 외래수술센터(ASC)의 확대와 상환 정책의 개선은 저침습 척추 기기 제조업체에 새로운 기회를 가져다주고 있습니다. 선진국의 인구 개발 및 신흥국 시장의 전문 의료 접근성 개선은 시장 확대에 더욱 기여하고 있습니다. 이러한 요인들이 결합되어 저침습 척추 장치는 기술 혁신, 임상적 증거, 저침습적 치료에 대한 세계 수요 증가에 힘입어 미래형 척추 치료 시스템의 핵심 구성 요소로 자리매김하고 있습니다.
부문
장치 유형 (내시경 장치, 투시 장치, 최소 침습 관 견인 장치, 기타 장치 유형); 애플리케이션 (척추 유합 시술 애플리케이션, 척추 비유합 시술 애플리케이션); 최종 용도 (바이오 제약 회사 최종 용도, 계약 연구 기관 최종 용도, 학술 및 연구 기관 최종 용도, 기타 최종 용도)
조사 대상 기업 예
Aesculap Inc.(B. Braun)
Alphatec Spine, Inc.
Amendia, Inc.
Aurora Spine Corporation
Bioventus Inc.
DePuy Synthes(Johnson & Johnson)
Globus Medical, Inc.
Joimax GmbH
Life Spine, Inc.
Medacta Group SA
Medtronic plc
NuVasive, Inc.
Orthofix Medical Inc.
RTI Surgical
SeaSpine Holdings Corporation
Spineart SA
Spinal Elements, Inc.
Stryker Corporation
Ulrich Medical
Zimmer Biomet Holdings, Inc.
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Minimal Invasive Spinal Devices Market to Reach US$1.4 Billion by 2030
The global market for Minimal Invasive Spinal Devices estimated at US$1.0 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Endoscope Device, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$582.0 Million by the end of the analysis period. Growth in the Fluoroscope Device segment is estimated at 3.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$278.6 Million While China is Forecast to Grow at 8.2% CAGR
The Minimal Invasive Spinal Devices market in the U.S. is estimated at US$278.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$276.2 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.
How Are Minimally Invasive Spinal Devices Revolutionizing Spinal Surgery and Patient Recovery?
Minimally invasive spinal devices are dramatically reshaping the field of spinal surgery by offering solutions that reduce tissue trauma, decrease recovery times, and improve overall surgical outcomes. Traditional open spine procedures often require large incisions, extended hospital stays, and prolonged rehabilitation due to the extensive muscle and tissue disruption involved. In contrast, minimally invasive techniques utilize specialized devices and instruments to access the spine through small incisions, guided by real-time imaging such as fluoroscopy or intraoperative navigation systems. These procedures result in less blood loss, reduced postoperative pain, and quicker mobilization for patients. Devices such as tubular retractors, endoscopic tools, and percutaneous pedicle screws allow surgeons to treat spinal conditions like herniated discs, spinal stenosis, and degenerative disc disease with high precision while preserving surrounding structures. Innovations in imaging and instrumentation have also enabled more complex procedures, including spinal fusion and deformity correction, to be performed using minimally invasive approaches. This shift not only benefits patient recovery but also improves operating room efficiency and lowers the risk of complications such as infections or adjacent segment degeneration. Surgeons are increasingly adopting these devices to treat a broader range of spinal pathologies, motivated by both clinical results and growing patient demand for faster, less invasive procedures. As a result, minimally invasive spinal devices are setting new standards in surgical care, helping hospitals reduce costs while delivering superior patient outcomes.
Why Is the Demand for Minimally Invasive Spinal Devices Surging Among Aging Populations and Active Lifestyles?
The demand for minimally invasive spinal devices is surging globally, driven largely by demographic trends and shifting patient expectations. One of the most significant contributors to market growth is the increasing prevalence of spinal disorders in aging populations. As life expectancy rises worldwide, so too does the incidence of age-related conditions such as spinal stenosis, spondylolisthesis, and osteoporotic fractures. Minimally invasive procedures are particularly well-suited to older patients, as they reduce the physiological burden of surgery and lower the risk of complications that are more common in elderly individuals. Additionally, today’s older adults are more active than previous generations and are often unwilling to endure the extended recovery periods associated with traditional open surgeries. On the other end of the spectrum, younger patients suffering from sports injuries or work-related spinal trauma are also seeking solutions that minimize downtime and allow for a rapid return to daily activities. This convergence of needs across different age groups is creating strong momentum for the adoption of advanced, minimally invasive devices. Furthermore, improvements in healthcare infrastructure and insurance coverage in emerging economies are making these treatments more accessible to broader patient populations. The combination of demographic shifts, increased awareness, and greater surgical availability is propelling the minimally invasive spinal device market to the forefront of modern orthopedic and neurological care.
How Are Technological Advancements Expanding the Capabilities of Minimally Invasive Spinal Devices?
Technological advancements are expanding the capabilities of minimally invasive spinal devices, enabling more precise, versatile, and patient-specific treatments than ever before. Innovations in robotic-assisted surgery, navigation systems, and real-time imaging are helping surgeons perform complex procedures with greater accuracy and minimal disruption to healthy tissues. Robotic platforms provide enhanced control and consistency during instrumentation placement, reducing variability and improving surgical outcomes. Intraoperative navigation systems, which use 3D imaging and augmented reality overlays, allow for detailed anatomical visualization, helping surgeons avoid critical structures while optimizing implant positioning. At the same time, the design of spinal implants has evolved significantly, with newer materials such as titanium alloys and polyetheretherketone (PEEK) offering improved biocompatibility, strength, and radiolucency. Expandable interbody cages and modular fixation systems are facilitating customized spinal alignment and load sharing, tailored to the unique needs of each patient. Additionally, device miniaturization and enhanced ergonomics are allowing for smaller incisions and quicker instrument exchanges during surgery. Some devices now feature integrated biologics delivery systems, enabling simultaneous placement of bone graft materials for improved fusion rates. The integration of data analytics and AI into surgical planning is further personalizing the selection and use of devices, optimizing outcomes for different patient profiles. As these technologies become more refined and widely adopted, they are redefining the standard of care in spinal surgery, pushing the boundaries of what can be achieved through minimally invasive approaches.
What Are the Key Drivers Behind the Global Growth of the Minimally Invasive Spinal Devices Market?
The growth in the minimally invasive spinal devices market is driven by a combination of clinical, technological, demographic, and economic factors that are reshaping spinal care globally. One of the foremost drivers is the proven clinical benefits of minimally invasive surgery, which include reduced postoperative pain, shorter hospital stays, faster recovery, and lower rates of complications. These outcomes translate into higher patient satisfaction and lower overall treatment costs, making the approach attractive to both providers and payers. Increasing awareness of these benefits among patients is also prompting more individuals to seek minimally invasive solutions, especially as information about surgical options becomes more widely accessible online and through healthcare networks. From a provider perspective, hospitals and surgical centers are prioritizing these procedures to meet demand, boost throughput, and remain competitive in the growing field of outpatient spine surgery. Technological advancements have made it possible to treat a broader range of spinal pathologies using minimally invasive methods, expanding the addressable market and encouraging wider adoption. Furthermore, the expansion of ambulatory surgical centers and improvements in reimbursement policies are creating new opportunities for minimally invasive spinal device manufacturers. Aging populations in developed nations and improving access to specialized care in emerging markets are further contributing to market expansion. Together, these factors are establishing minimally invasive spinal devices as a core component of future-ready spinal care systems, supported by innovation, clinical evidence, and growing global demand for less invasive treatment alternatives.
SCOPE OF STUDY:
The report analyzes the Minimal Invasive Spinal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Device Type (Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device, Other Device Types); Application (Spine Fusion Procedure Application, Spine Non-Fusion Procedure Application); End-Use (Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use, Academic & Research Institutes End-Use, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 41 Featured) -
Aesculap Inc. (B. Braun)
Alphatec Spine, Inc.
Amendia, Inc.
Aurora Spine Corporation
Bioventus Inc.
DePuy Synthes (Johnson & Johnson)
Globus Medical, Inc.
Joimax GmbH
Life Spine, Inc.
Medacta Group SA
Medtronic plc
NuVasive, Inc.
Orthofix Medical Inc.
RTI Surgical
SeaSpine Holdings Corporation
Spineart SA
Spinal Elements, Inc.
Stryker Corporation
Ulrich Medical
Zimmer Biomet Holdings, Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Tariff Impact on Global Supply Chain Patterns
Minimal Invasive Spinal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Incidence of Degenerative Spinal Disorders Throws the Spotlight on Minimally Invasive Solutions
Surge in Geriatric Population Drives Demand for Low-Trauma Spinal Devices with Faster Recovery Profiles
Technological Advancements in Navigation and Imaging Systems Propel Adoption of Precision-Guided Implants
Shift Toward Outpatient and Ambulatory Surgical Settings Strengthens the Business Case for Minimally Invasive Devices
Growing Preference for Motion Preservation Techniques Spurs Innovation in Dynamic Stabilization Implants
Reduced Hospital Stay and Postoperative Complications Fuels Growth of MIS Spinal Technologies
Expanding Use of Robotics and AI in Spine Surgery Accelerates Demand for Compatible Minimally Invasive Systems
Increasing Acceptance of Minimally Invasive Fusion Techniques Generates Demand for Advanced Interbody Devices
Surge in Sports Injuries and Trauma Cases Among Young Adults Drives Adoption of MIS Interventions
Integration of Augmented Reality in Surgical Workflows Enhances Accuracy and Broadens Adoption of MIS Devices
Rising Patient Awareness and Demand for Cosmetic and Functional Outcomes Spur Market Penetration
Growth in Spinal Endoscopy and Percutaneous Approaches Expands the Addressable Market for Specialized Devices
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Minimal Invasive Spinal Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Minimal Invasive Spinal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 4: World 16-Year Perspective for Minimal Invasive Spinal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Endoscope Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Endoscope Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 7: World 16-Year Perspective for Endoscope Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Fluoroscope Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Fluoroscope Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 10: World 16-Year Perspective for Fluoroscope Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Minimally Invasive Tubular Retractor Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Minimally Invasive Tubular Retractor Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 13: World 16-Year Perspective for Minimally Invasive Tubular Retractor Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Other Device Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 16: World 16-Year Perspective for Other Device Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Biopharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 22: World 16-Year Perspective for Biopharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 25: World 16-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 28: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Spine Fusion Procedure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Spine Fusion Procedure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 31: World 16-Year Perspective for Spine Fusion Procedure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Spine Non-Fusion Procedure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Spine Non-Fusion Procedure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 34: World 16-Year Perspective for Spine Non-Fusion Procedure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: USA Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 37: USA 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 40: USA 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 43: USA 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 46: Canada 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 49: Canada 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 52: Canada 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
JAPAN
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 55: Japan 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 58: Japan 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 61: Japan 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
CHINA
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 62: China Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: China Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 64: China 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: China Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 67: China 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: China Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 70: China 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
EUROPE
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 71: Europe Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Minimal Invasive Spinal Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 73: Europe 16-Year Perspective for Minimal Invasive Spinal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 76: Europe 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 79: Europe 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 82: Europe 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
FRANCE
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 83: France Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: France Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 85: France 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: France Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 88: France 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: France Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 91: France 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
GERMANY
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 92: Germany Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 94: Germany 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 97: Germany 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 100: Germany 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
ITALY
TABLE 101: Italy Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 103: Italy 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 106: Italy 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 109: Italy 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
UNITED KINGDOM
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 110: UK Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 111: UK Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 112: UK 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 114: UK Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 115: UK 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: UK Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 118: UK 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
SPAIN
TABLE 119: Spain Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 121: Spain 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 122: Spain Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 124: Spain 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 127: Spain 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
RUSSIA
TABLE 128: Russia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 130: Russia 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 131: Russia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 133: Russia 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 136: Russia 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
REST OF EUROPE
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 145: Rest of Europe 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
ASIA-PACIFIC
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Minimal Invasive Spinal Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Minimal Invasive Spinal Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
AUSTRALIA
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 158: Australia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 160: Australia 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 161: Australia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 163: Australia 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 166: Australia 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
INDIA
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 167: India Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 168: India Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 169: India 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 170: India Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 171: India Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 172: India 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 174: India Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 175: India 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
SOUTH KOREA
TABLE 176: South Korea Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 179: South Korea Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 181: South Korea 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 184: South Korea 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
LATIN AMERICA
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 194: Latin America Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Minimal Invasive Spinal Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Minimal Invasive Spinal Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
ARGENTINA
TABLE 206: Argentina Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 209: Argentina Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 211: Argentina 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 214: Argentina 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
BRAZIL
TABLE 215: Brazil Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 218: Brazil Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 220: Brazil 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 223: Brazil 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
MEXICO
TABLE 224: Mexico Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 227: Mexico Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 229: Mexico 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 232: Mexico 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 238: Rest of Latin America 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 241: Rest of Latin America 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
MIDDLE EAST
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 242: Middle East Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Minimal Invasive Spinal Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Minimal Invasive Spinal Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
IRAN
TABLE 254: Iran Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 256: Iran 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 257: Iran Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 259: Iran 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 262: Iran 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
ISRAEL
TABLE 263: Israel Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 265: Israel 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 266: Israel Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 268: Israel 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 271: Israel 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
SAUDI ARABIA
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 277: Saudi Arabia 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 280: Saudi Arabia 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 281: UAE Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 283: UAE 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 284: UAE Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 286: UAE 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 289: UAE 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 295: Rest of Middle East 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 298: Rest of Middle East 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030
AFRICA
Minimal Invasive Spinal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 299: Africa Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Minimal Invasive Spinal Devices by Device Type - Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 301: Africa 16-Year Perspective for Minimal Invasive Spinal Devices by Device Type - Percentage Breakdown of Value Sales for Endoscope Device, Fluoroscope Device, Minimally Invasive Tubular Retractor Device and Other Device Types for the Years 2014, 2025 & 2030
TABLE 302: Africa Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Minimal Invasive Spinal Devices by End-Use - Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 304: Africa 16-Year Perspective for Minimal Invasive Spinal Devices by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Biopharmaceutical Companies End-Use, Contract Research Organizations End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Minimal Invasive Spinal Devices by Application - Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
TABLE 307: Africa 16-Year Perspective for Minimal Invasive Spinal Devices by Application - Percentage Breakdown of Value Sales for Spine Fusion Procedure Application and Spine Non-Fusion Procedure Application for the Years 2014, 2025 & 2030